Health Care: Drugs

Pacira Pharmaceuticals Inc. (PCRX: NASDAQ)

$64.21 0.28 | 0.44%
04/15/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 85.55M 39.08M 15.69M 14.56M
Cost of Sales 44.61M 25.90M 10.87M 8.02M
Gross Operating Profit 40.94M 13.18M 4.82M 6.54M
Selling, General, and Administrative Expenses 62.51M 46.31M 20.16M 6.03M
Research & Development 21.56M 9.94M 14.87M 18.63M
Operating Income before D & A (EBITDA) -43.12M -43.06M -30.21M -18.12M
Depreciation & Amortization 10.16M 6.24M 5.87M 4.25M
Interest Income 259.00K 275.00K 255.00K 146.00K
Other Income - Net -4.07M -1.45M 298.00K -34.00K
Special Income / Charges 0.00 0.00 -3.02M 0.00
Total Income Before Interest Expenses (EBIT) -57.10M -50.47M -38.55M -22.26M
Interest Expense 7.25M 1.81M 4.78M 4.89M
Pre-Tax Income -64.35M -52.28M -43.33M -27.15M
Income Taxes -442.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -63.91M -52.28M -43.33M -27.15M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -63.91M -52.28M -43.33M -27.15M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -63.91M -52.28M -43.33M -27.15M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-63.91M -52.28M -40.31M -27.15M
Preferred Dividends
Net Income Available To Common -63.91M -52.28M -43.33M -27.15M
Basic EPS from Continuing Ops. -1.93 -1.72 -2.64 -47.29
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.93 -1.72 -2.64 -47.29
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.93 -1.72 -2.64 -47.29
Basic Normalized Net Income/Share -1.93 -1.72 -2.45 -47.29
EPS fr Continuing Ops. -1.93 -1.72 -2.64 -47.29
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.93 -1.72 -2.64 -47.29
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.93 -1.72 -2.64 -47.29
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.93 -1.72 -2.45 -47.29
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PCRX

Latest PCRX Headlines from TheStreet

More Financial News for PCRX

Press Releases for PCRX

See All Press Releases

Partner Headlines for PCRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter